Minden Collamore

1.5k total citations
8 papers, 1.2k citations indexed

About

Minden Collamore is a scholar working on Oncology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Minden Collamore has authored 8 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Minden Collamore's work include Thyroid Cancer Diagnosis and Treatment (4 papers), Histone Deacetylase Inhibitors Research (3 papers) and Cancer-related Molecular Pathways (2 papers). Minden Collamore is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (4 papers), Histone Deacetylase Inhibitors Research (3 papers) and Cancer-related Molecular Pathways (2 papers). Minden Collamore collaborates with scholars based in United States. Minden Collamore's co-authors include Manisha H. Shah, Daria Arbogast, Michael R. Grever, Matthew D. Ringel, Richard T. Kloos, Michael V. Knopp, James R. Wright, Lai Wei, Nathan C. Hall and Jiachao Liang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Minden Collamore

8 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minden Collamore United States 7 637 470 395 158 127 8 1.2k
Tomoo Ueno Japan 20 327 0.5× 512 1.1× 541 1.4× 197 1.2× 65 0.5× 23 2.2k
Douglas Burtrum United States 14 298 0.5× 439 0.9× 806 2.0× 58 0.4× 81 0.6× 18 1.7k
Mary B. Breslin United States 20 153 0.2× 333 0.7× 553 1.4× 377 2.4× 222 1.7× 37 1.3k
Renata Lonigro Italy 14 219 0.3× 117 0.2× 631 1.6× 234 1.5× 44 0.3× 23 952
Katja Kiseljak‐Vassiliades United States 20 532 0.8× 174 0.4× 398 1.0× 100 0.6× 109 0.9× 48 1.2k
Roy A. Lynch United States 12 432 0.7× 192 0.4× 1.1k 2.7× 195 1.2× 193 1.5× 16 1.9k
Francesca Lessi Italy 19 146 0.2× 203 0.4× 350 0.9× 120 0.8× 100 0.8× 57 863
Avital Swisa Israel 16 255 0.4× 111 0.2× 755 1.9× 317 2.0× 94 0.7× 19 1.3k
Satsuki Matsushima Japan 19 89 0.1× 173 0.4× 536 1.4× 134 0.8× 47 0.4× 38 1.0k
Hicham Lahlou France 13 101 0.2× 263 0.6× 335 0.8× 38 0.2× 204 1.6× 14 843

Countries citing papers authored by Minden Collamore

Since Specialization
Citations

This map shows the geographic impact of Minden Collamore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minden Collamore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minden Collamore more than expected).

Fields of papers citing papers by Minden Collamore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minden Collamore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minden Collamore. The network helps show where Minden Collamore may publish in the future.

Co-authorship network of co-authors of Minden Collamore

This figure shows the co-authorship network connecting the top 25 collaborators of Minden Collamore. A scholar is included among the top collaborators of Minden Collamore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minden Collamore. Minden Collamore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lam, Elaine T., Matthew D. Ringel, Richard T. Kloos, et al.. (2010). Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer. Journal of Clinical Oncology. 28(14). 2323–2330. 288 indexed citations
2.
Kloos, Richard T., Matthew D. Ringel, Michael V. Knopp, et al.. (2009). Phase II Trial of Sorafenib in Metastatic Thyroid Cancer. Journal of Clinical Oncology. 27(10). 1675–1684. 430 indexed citations
3.
Shah, Manisha H., Kimberly A. Varker, Minden Collamore, et al.. (2009). G3139 (Genasense) in Patients With Advanced Merkel Cell Carcinoma. American Journal of Clinical Oncology. 32(2). 174–179. 34 indexed citations
4.
Woyach, Jennifer A., Richard T. Kloos, Matthew D. Ringel, et al.. (2008). Lack of Therapeutic Effect of the Histone Deacetylase Inhibitor Vorinostat in Patients with Metastatic Radioiodine-Refractory Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 94(1). 164–170. 129 indexed citations
5.
Kloos, Richard T., Matthew D. Ringel, Michael V. Knopp, et al.. (2006). Significant clinical and biologic activity of RAF/VEGF-R kinase inhibitor BAY 43–9006 in patients with metastatic papillary thyroid carcinoma (PTC): Updated results of a phase II study. Journal of Clinical Oncology. 24(18_suppl). 5534–5534. 26 indexed citations
6.
Shah, Manisha H., Philip F. Binkley, Kenneth K. Chan, et al.. (2006). Cardiotoxicity of Histone Deacetylase Inhibitor Depsipeptide in Patients with Metastatic Neuroendocrine Tumors. Clinical Cancer Research. 12(13). 3997–4003. 190 indexed citations
7.
Shapiro, Charles L., Donn C. Young, D. Lucas, et al.. (2005). Phase I trial of bortezomib in combination with paclitaxel in advanced solid tumor patients (pts). Journal of Clinical Oncology. 23(16_suppl). 3104–3104. 5 indexed citations
8.
Butcher, Greg Q., Heather Dziema, Minden Collamore, Penny W. Burgoon, & Karl Obrietan. (2002). The p42/44 Mitogen-activated Protein Kinase Pathway Couples Photic Input to Circadian Clock Entrainment. Journal of Biological Chemistry. 277(33). 29519–29525. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026